€1.1m deal over cloning technology rights
The intellectual property rights to cloning technology that helped spawn Dolly the sheep changed hands today in a £760,000 (€1.1m) deal.
Biotech firm PPL Therapeutics agreed to transfer ownership of the nuclear transfer patents and related know-how from the Roslin Institute in Edinburgh to US-based Exeter Life Sciences.